Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

NCT05563558 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Cabazitaxel

Sponsor

Fundacion Oncosur